Want to join the conversation?
$PFE raised its 2015 adjusted net income forecast to $2.16-2.20 a share, up from the $2.04-2.10 a share the company guided to in Sept. 2015 after completing the Hospira acquisition. Revenue is expected to be between $47.5-48.5Bil, up from $46.5-47.5Bil previously announced.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.